25 XP   0   0   10

Fresenius SE & Co. KGaA
Buy, Hold or Sell?

Let's analyse Fresenius together

PenkeI guess you are interested in Fresenius SE & Co. KGaA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fresenius SE & Co. KGaA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Fresenius SE & Co. KGaA

I send you an email if I find something interesting about Fresenius SE & Co. KGaA.

Quick analysis of Fresenius (30 sec.)










What can you expect buying and holding a share of Fresenius? (30 sec.)

How much money do you get?

How much money do you get?
€2.34
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€34.89
Expected worth in 1 year
€12.58
How sure are you?
82.5%

+ What do you gain per year?

Total Gains per Share
€-20.13
Return On Investment
-74.0%

For what price can you sell your share?

Current Price per Share
€27.21
Expected price per share
€24.41 - €29.38
How sure are you?
50%

1. Valuation of Fresenius (5 min.)




Live pricePrice per Share (EOD)

€27.21

Intrinsic Value Per Share

€46.87 - €90.30

Total Value Per Share

€81.76 - €125.19

2. Growth of Fresenius (5 min.)




Is Fresenius growing?

Current yearPrevious yearGrowGrow %
How rich?$21b$34.5b-$4.1b-13.6%

How much money is Fresenius making?

Current yearPrevious yearGrowGrow %
Making money-$158.8m$366.9m-$525.8m-331.0%
Net Profit Margin-3.5%3.4%--

How much money comes from the company's main activities?

3. Financial Health of Fresenius (5 min.)




4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#2 / 186

Most Revenue
#3 / 186

Most Profit
#182 / 186

Most Efficient
#134 / 186

What can you expect buying and holding a share of Fresenius? (5 min.)

Welcome investor! Fresenius's management wants to use your money to grow the business. In return you get a share of Fresenius.

What can you expect buying and holding a share of Fresenius?

First you should know what it really means to hold a share of Fresenius. And how you can make/lose money.

Speculation

The Price per Share of Fresenius is €27.21. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fresenius.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fresenius, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €34.89. Based on the TTM, the Book Value Change Per Share is €-5.58 per quarter. Based on the YOY, the Book Value Change Per Share is €1.30 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.55 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fresenius.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-1.17-4.3%-0.28-1.0%0.652.4%0.592.2%0.672.5%
Usd Book Value Change Per Share-20.19-74.2%-5.97-21.9%1.395.1%-0.51-1.9%0.281.0%
Usd Dividend Per Share0.010.0%0.582.1%0.421.6%0.491.8%0.431.6%
Usd Total Gains Per Share-20.18-74.2%-5.38-19.8%1.816.7%-0.01-0.1%0.712.6%
Usd Price Per Share30.03-28.82-29.54-38.64-55.15-
Price to Earnings Ratio-6.44-9.53-11.53-12.11-18.84-
Price-to-Total Gains Ratio-1.49-472.48-4.80-67.07-76.93-
Price to Book Ratio0.80-0.56-0.49-0.74-1.37-
Price-to-Total Gains Ratio-1.49-472.48-4.80-67.07-76.93-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share29.111979
Number of shares34
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.580.49
Usd Book Value Change Per Share-5.97-0.51
Usd Total Gains Per Share-5.38-0.01
Gains per Quarter (34 shares)-183.05-0.51
Gains per Year (34 shares)-732.20-2.03
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
179-812-74267-69-12
2159-1623-1474134-138-14
3238-2435-2206202-208-16
4318-3247-2938269-277-18
5397-4058-3670336-346-20
6477-4870-4402403-415-22
7556-5681-5134470-484-24
8636-6493-5866537-554-26
9715-7305-6598605-623-28
10794-8116-7330672-692-30

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%10.02.00.083.3%18.02.00.090.0%38.02.00.095.0%58.02.00.096.7%
Book Value Change Per Share0.04.00.00.0%6.06.00.050.0%10.010.00.050.0%28.012.00.070.0%41.016.03.068.3%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%40.00.00.0100.0%60.00.00.0100.0%
Total Gains per Share2.02.00.050.0%9.03.00.075.0%14.06.00.070.0%33.07.00.082.5%51.09.00.085.0%

Fundamentals of Fresenius

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Fundamental data was last updated by Penke on 2024-04-10 04:32:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is underpriced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Fresenius SE & Co. KGaA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Fresenius earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -10.8% means that €-0.11 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fresenius SE & Co. KGaA:

  • The MRQ is -10.8%. The company is making a huge loss. -2
  • The TTM is -3.5%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-10.8%TTM-3.5%-7.3%
TTM-3.5%YOY3.4%-6.9%
TTM-3.5%5Y2.9%-6.5%
5Y2.9%10Y4.1%-1.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-10.8%2.5%-13.3%
TTM-3.5%2.4%-5.9%
YOY3.4%3.5%-0.1%
5Y2.9%3.1%-0.2%
10Y4.1%3.7%+0.4%
1.1.2. Return on Assets

Shows how efficient Fresenius is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • -1.4% Return on Assets means that Fresenius generated €-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fresenius SE & Co. KGaA:

  • The MRQ is -1.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-0.3%-1.0%
TTM-0.3%YOY0.5%-0.8%
TTM-0.3%5Y0.4%-0.8%
5Y0.4%10Y0.6%-0.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%0.7%-2.1%
TTM-0.3%0.6%-0.9%
YOY0.5%1.1%-0.6%
5Y0.4%0.9%-0.5%
10Y0.6%1.2%-0.6%
1.1.3. Return on Equity

Shows how efficient Fresenius is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • -3.2% Return on Equity means Fresenius generated €-0.03 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fresenius SE & Co. KGaA:

  • The MRQ is -3.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.2%TTM-0.8%-2.4%
TTM-0.8%YOY1.7%-2.5%
TTM-0.8%5Y1.7%-2.5%
5Y1.7%10Y2.5%-0.8%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.2%2.1%-5.3%
TTM-0.8%2.1%-2.9%
YOY1.7%2.8%-1.1%
5Y1.7%2.3%-0.6%
10Y2.5%2.7%-0.2%

1.2. Operating Efficiency of Fresenius SE & Co. KGaA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Fresenius is operating .

  • Measures how much profit Fresenius makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • An Operating Margin of 3.4% means the company generated €0.03  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fresenius SE & Co. KGaA:

  • The MRQ is 3.4%. The company is operating less efficient.
  • The TTM is 8.1%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ3.4%TTM8.1%-4.7%
TTM8.1%YOY8.6%-0.5%
TTM8.1%5Y8.7%-0.6%
5Y8.7%10Y9.9%-1.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4%6.7%-3.3%
TTM8.1%6.7%+1.4%
YOY8.6%7.0%+1.6%
5Y8.7%6.4%+2.3%
10Y9.9%8.1%+1.8%
1.2.2. Operating Ratio

Measures how efficient Fresenius is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are €0.99 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Fresenius SE & Co. KGaA:

  • The MRQ is 0.985. The company is less efficient in keeping operating costs low.
  • The TTM is 0.948. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.985TTM0.948+0.037
TTM0.948YOY0.918+0.030
TTM0.9485Y0.901+0.047
5Y0.90110Y0.882+0.020
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9851.161-0.176
TTM0.9481.105-0.157
YOY0.9181.028-0.110
5Y0.9011.026-0.125
10Y0.8821.004-0.122

1.3. Liquidity of Fresenius SE & Co. KGaA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Fresenius is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 1.34 means the company has €1.34 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Fresenius SE & Co. KGaA:

  • The MRQ is 1.342. The company is just able to pay all its short-term debts.
  • The TTM is 1.320. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.342TTM1.320+0.022
TTM1.320YOY1.309+0.011
TTM1.3205Y1.194+0.126
5Y1.19410Y1.261-0.067
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3421.285+0.057
TTM1.3201.304+0.016
YOY1.3091.342-0.033
5Y1.1941.385-0.191
10Y1.2611.424-0.163
1.3.2. Quick Ratio

Measures if Fresenius is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • A Quick Ratio of 0.73 means the company can pay off €0.73 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fresenius SE & Co. KGaA:

  • The MRQ is 0.728. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.833. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.728TTM0.833-0.106
TTM0.833YOY0.762+0.072
TTM0.8335Y0.737+0.096
5Y0.73710Y0.773-0.036
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7280.893-0.165
TTM0.8330.946-0.113
YOY0.7621.056-0.294
5Y0.7371.159-0.422
10Y0.7731.146-0.373

1.4. Solvency of Fresenius SE & Co. KGaA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Fresenius assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fresenius to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.57 means that Fresenius assets are financed with 56.6% credit (debt) and the remaining percentage (100% - 56.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fresenius SE & Co. KGaA:

  • The MRQ is 0.566. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.583. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.566TTM0.583-0.017
TTM0.583YOY0.579+0.005
TTM0.5835Y0.596-0.013
5Y0.59610Y0.586+0.009
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5660.518+0.048
TTM0.5830.546+0.037
YOY0.5790.522+0.057
5Y0.5960.564+0.032
10Y0.5860.529+0.057
1.4.2. Debt to Equity Ratio

Measures if Fresenius is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fresenius to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 134.9% means that company has €1.35 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fresenius SE & Co. KGaA:

  • The MRQ is 1.349. The company is able to pay all its debts with equity. +1
  • The TTM is 2.000. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.349TTM2.000-0.650
TTM2.000YOY2.149-0.150
TTM2.0005Y2.271-0.271
5Y2.27110Y2.280-0.009
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3490.912+0.437
TTM2.0000.952+1.048
YOY2.1491.078+1.071
5Y2.2711.231+1.040
10Y2.2801.261+1.019

2. Market Valuation of Fresenius SE & Co. KGaA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Fresenius generates.

  • Above 15 is considered overpriced but always compare Fresenius to the Medical Care Facilities industry mean.
  • A PE ratio of -6.44 means the investor is paying €-6.44 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fresenius SE & Co. KGaA:

  • The EOD is -6.240. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.437. Based on the earnings, the company is expensive. -2
  • The TTM is 9.528. Based on the earnings, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD-6.240MRQ-6.437+0.197
MRQ-6.437TTM9.528-15.965
TTM9.528YOY11.529-2.001
TTM9.5285Y12.110-2.582
5Y12.11010Y18.839-6.730
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-6.24011.569-17.809
MRQ-6.43710.707-17.144
TTM9.52814.196-4.668
YOY11.52911.894-0.365
5Y12.11017.599-5.489
10Y18.83920.381-1.542
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fresenius SE & Co. KGaA:

  • The EOD is 2.536. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 2.616. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is -0.717. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD2.536MRQ2.616-0.080
MRQ2.616TTM-0.717+3.333
TTM-0.717YOY-1.004+0.287
TTM-0.7175Y5.114-5.831
5Y5.11410Y-47.903+53.017
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD2.5368.673-6.137
MRQ2.6167.539-4.923
TTM-0.7177.539-8.256
YOY-1.0046.337-7.341
5Y5.1146.951-1.837
10Y-47.9035.303-53.206
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Fresenius is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 0.80 means the investor is paying €0.80 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Fresenius SE & Co. KGaA:

  • The EOD is 0.780. Based on the equity, the company is cheap. +2
  • The MRQ is 0.805. Based on the equity, the company is cheap. +2
  • The TTM is 0.561. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.780MRQ0.805-0.025
MRQ0.805TTM0.561+0.244
TTM0.561YOY0.486+0.075
TTM0.5615Y0.739-0.178
5Y0.73910Y1.371-0.632
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD0.7801.858-1.078
MRQ0.8051.861-1.056
TTM0.5611.942-1.381
YOY0.4862.124-1.638
5Y0.7392.374-1.635
10Y1.3712.501-1.130
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Fresenius SE & Co. KGaA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---18.875-5.578-70%1.301-1551%-0.476-97%0.263-7284%
Book Value Per Share--34.88950.394-31%57.254-39%50.207-31%42.550-18%
Current Ratio--1.3421.320+2%1.309+3%1.194+12%1.261+6%
Debt To Asset Ratio--0.5660.583-3%0.579-2%0.596-5%0.586-3%
Debt To Equity Ratio--1.3492.000-33%2.149-37%2.271-41%2.280-41%
Dividend Per Share--0.0110.546-98%0.395-97%0.462-98%0.399-97%
Eps---1.090-0.264-76%0.609-279%0.549-299%0.627-274%
Free Cash Flow Per Share--2.6831.475+82%1.012+165%1.099+144%0.610+339%
Free Cash Flow To Equity Per Share--2.6860.863+211%0.300+794%0.386+596%0.284+845%
Gross Profit Margin--2.2211.305+70%-0.196+109%0.488+355%0.521+326%
Intrinsic Value_10Y_max--90.302--------
Intrinsic Value_10Y_min--46.874--------
Intrinsic Value_1Y_max--5.688--------
Intrinsic Value_1Y_min--2.843--------
Intrinsic Value_3Y_max--19.651--------
Intrinsic Value_3Y_min--10.199--------
Intrinsic Value_5Y_max--36.703--------
Intrinsic Value_5Y_min--19.314--------
Market Cap15325678552.320-3%15810070365.39015172198471.988+4%15551677395.360+2%20342430840.062-22%29031977731.830-46%
Net Profit Margin---0.108-0.035-68%0.034-420%0.029-467%0.041-363%
Operating Margin--0.0340.081-58%0.086-61%0.087-61%0.099-66%
Operating Ratio--0.9850.948+4%0.918+7%0.901+9%0.882+12%
Pb Ratio0.780-3%0.8050.561+44%0.486+66%0.739+9%1.371-41%
Pe Ratio-6.240+3%-6.4379.528-168%11.529-156%12.110-153%18.839-134%
Price Per Share27.210-3%28.07026.938+4%27.611+2%36.117-22%51.545-46%
Price To Free Cash Flow Ratio2.536-3%2.616-0.717+127%-1.004+138%5.114-49%-47.903+1931%
Price To Total Gains Ratio-1.442+3%-1.488472.477-100%4.800-131%67.072-102%76.932-102%
Quick Ratio--0.7280.833-13%0.762-4%0.737-1%0.773-6%
Return On Assets---0.014-0.003-75%0.005-401%0.004-423%0.006-316%
Return On Equity---0.032-0.008-75%0.017-293%0.017-285%0.025-228%
Total Gains Per Share---18.864-5.032-73%1.696-1213%-0.014-100%0.662-2951%
Usd Book Value--21024604900.00030368041600.000-31%34501867725.000-39%30254953170.000-31%25640741945.000-18%
Usd Book Value Change Per Share---20.194-5.968-70%1.391-1551%-0.509-97%0.281-7284%
Usd Book Value Per Share--37.32853.917-31%61.256-39%53.716-31%45.524-18%
Usd Dividend Per Share--0.0110.584-98%0.423-97%0.494-98%0.427-97%
Usd Eps---1.166-0.282-76%0.652-279%0.588-299%0.671-274%
Usd Free Cash Flow--1616618900.000888551950.000+82%610110475.000+165%662375090.000+144%367885115.000+339%
Usd Free Cash Flow Per Share--2.8701.578+82%1.083+165%1.176+144%0.653+339%
Usd Free Cash Flow To Equity Per Share--2.8740.924+211%0.321+794%0.413+596%0.304+845%
Usd Market Cap16396943483.127-3%16915194283.93116232735145.179+4%16638739645.296+2%21764366755.782-22%31061312975.285-46%
Usd Price Per Share29.112-3%30.03228.820+4%29.541+2%38.642-22%55.148-46%
Usd Profit---656918600.000-158880150.000-76%366975700.000-279%330920070.000-299%375668637.500-275%
Usd Revenue--6074892200.0008500355500.000-29%10923679000.000-44%9726781870.000-38%8804795545.000-31%
Usd Total Gains Per Share---20.183-5.384-73%1.814-1213%-0.015-100%0.708-2951%
 EOD+4 -4MRQTTM+13 -23YOY+13 -235Y+12 -2410Y+12 -24

3.2. Fundamental Score

Let's check the fundamental score of Fresenius SE & Co. KGaA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.240
Price to Book Ratio (EOD)Between0-10.780
Net Profit Margin (MRQ)Greater than0-0.108
Operating Margin (MRQ)Greater than00.034
Quick Ratio (MRQ)Greater than10.728
Current Ratio (MRQ)Greater than11.342
Debt to Asset Ratio (MRQ)Less than10.566
Debt to Equity Ratio (MRQ)Less than11.349
Return on Equity (MRQ)Greater than0.15-0.032
Return on Assets (MRQ)Greater than0.05-0.014
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Fresenius SE & Co. KGaA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.925
Ma 20Greater thanMa 5026.025
Ma 50Greater thanMa 10025.713
Ma 100Greater thanMa 20026.545
OpenGreater thanClose27.120
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Income before Tax  555,00062,000617,000-258,000359,000-113,000246,000-298,000-52,000
Net Income from Continuing Operations  403,00060,000463,000-297,000166,000-11,000155,000-372,000-217,000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets45,284,000
Total Liabilities25,633,000
Total Stockholder Equity18,999,000
 As reported
Total Liabilities 25,633,000
Total Stockholder Equity+ 18,999,000
Total Assets = 45,284,000

Assets

Total Assets45,284,000
Total Current Assets12,520,000
Long-term Assets32,764,000
Total Current Assets
Cash And Cash Equivalents 2,289,000
Net Receivables 4,501,000
Inventory 2,517,000
Other Current Assets 3,213,000
Total Current Assets  (as reported)12,520,000
Total Current Assets  (calculated)12,520,000
+/-0
Long-term Assets
Property Plant Equipment 10,782,000
Goodwill 15,089,000
Intangible Assets 2,531,000
Long-term Assets Other 502,000
Long-term Assets  (as reported)32,764,000
Long-term Assets  (calculated)28,904,000
+/- 3,860,000

Liabilities & Shareholders' Equity

Total Current Liabilities9,330,000
Long-term Liabilities16,303,000
Total Stockholder Equity18,999,000
Total Current Liabilities
Short-term Debt 2,581,000
Short Long Term Debt 2,375,000
Accounts payable 1,985,000
Other Current Liabilities 1,903,000
Total Current Liabilities  (as reported)9,330,000
Total Current Liabilities  (calculated)8,844,000
+/- 486,000
Long-term Liabilities
Long term Debt 11,457,000
Capital Lease Obligations 1,998,000
Long-term Liabilities Other 140,000
Long-term Liabilities  (as reported)16,303,000
Long-term Liabilities  (calculated)13,595,000
+/- 2,708,000
Total Stockholder Equity
Common Stock563,000
Retained Earnings 14,092,000
Accumulated Other Comprehensive Income 18,000
Other Stockholders Equity 4,326,000
Total Stockholder Equity (as reported)18,999,000
Total Stockholder Equity (calculated)18,999,000
+/-0
Other
Capital Stock563,000
Cash and Short Term Investments 2,289,000
Common Stock Shares Outstanding 563,237
Current Deferred Revenue2,861,000
Liabilities and Stockholders Equity 45,284,000
Net Debt 13,541,000
Net Invested Capital 32,831,000
Net Working Capital 3,190,000
Property Plant and Equipment Gross 17,580,000
Short Long Term Debt Total 15,830,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-31
> Total Assets 
0
0
0
20,882,000
22,048,000
23,907,000
22,734,000
23,577,000
23,572,000
23,909,000
24,707,000
26,321,000
28,542,000
30,758,000
30,225,000
30,664,000
31,311,000
30,973,000
30,678,000
32,758,000
34,284,000
35,502,000
37,718,000
39,897,000
43,032,000
42,271,000
42,169,000
43,170,000
42,445,000
43,821,000
44,075,000
46,447,000
54,418,000
52,897,000
53,097,000
53,133,000
53,502,000
54,982,000
55,723,000
56,703,000
64,985,000
64,929,000
66,759,000
67,006,000
68,972,000
69,554,000
68,321,000
66,646,000
68,966,000
69,655,000
71,081,000
71,962,000
73,114,000
76,112,000
80,328,000
76,415,000
76,553,000
76,413,000
75,328,000
45,284,000
45,284,00075,328,00076,413,00076,553,00076,415,00080,328,00076,112,00073,114,00071,962,00071,081,00069,655,00068,966,00066,646,00068,321,00069,554,00068,972,00067,006,00066,759,00064,929,00064,985,00056,703,00055,723,00054,982,00053,502,00053,133,00053,097,00052,897,00054,418,00046,447,00044,075,00043,821,00042,445,00043,170,00042,169,00042,271,00043,032,00039,897,00037,718,00035,502,00034,284,00032,758,00030,678,00030,973,00031,311,00030,664,00030,225,00030,758,00028,542,00026,321,00024,707,00023,909,00023,572,00023,577,00022,734,00023,907,00022,048,00020,882,000000
   > Total Current Assets 
0
0
0
5,363,000
5,795,000
6,474,000
6,392,000
6,435,000
6,808,000
6,752,000
6,836,000
7,151,000
7,682,000
8,967,000
8,621,000
8,113,000
8,267,000
8,257,000
8,188,000
7,972,000
8,656,000
9,464,000
9,584,000
10,028,000
10,688,000
10,513,000
10,550,000
10,917,000
10,584,000
11,000,000
11,135,000
11,799,000
13,077,000
12,799,000
12,870,000
12,604,000
13,409,000
14,287,000
14,593,000
14,790,000
14,958,000
14,851,000
15,180,000
15,264,000
16,341,000
17,153,000
16,833,000
15,772,000
16,693,000
16,901,000
17,334,000
17,461,000
18,002,000
18,818,000
19,443,000
18,279,000
19,102,000
19,305,000
44,835,000
12,520,000
12,520,00044,835,00019,305,00019,102,00018,279,00019,443,00018,818,00018,002,00017,461,00017,334,00016,901,00016,693,00015,772,00016,833,00017,153,00016,341,00015,264,00015,180,00014,851,00014,958,00014,790,00014,593,00014,287,00013,409,00012,604,00012,870,00012,799,00013,077,00011,799,00011,135,00011,000,00010,584,00010,917,00010,550,00010,513,00010,688,00010,028,0009,584,0009,464,0008,656,0007,972,0008,188,0008,257,0008,267,0008,113,0008,621,0008,967,0007,682,0007,151,0006,836,0006,752,0006,808,0006,435,0006,392,0006,474,0005,795,0005,363,000000
       Cash And Cash Equivalents 
0
0
0
420,000
467,000
608,000
660,000
769,000
894,000
608,000
654,000
635,000
855,000
1,015,000
968,000
885,000
850,000
842,000
873,000
864,000
829,000
1,070,000
1,035,000
1,175,000
992,000
917,000
975,000
1,044,000
882,000
1,098,000
1,185,000
1,579,000
1,480,000
1,371,000
1,472,000
1,636,000
1,484,000
2,267,000
2,456,000
2,709,000
1,543,000
1,463,000
1,599,000
1,654,000
2,028,000
3,073,000
2,658,000
1,837,000
1,877,000
2,250,000
2,413,000
2,610,000
2,077,000
2,129,000
2,128,000
2,175,000
2,321,000
2,471,000
1,095,000
2,289,000
2,289,0001,095,0002,471,0002,321,0002,175,0002,128,0002,129,0002,077,0002,610,0002,413,0002,250,0001,877,0001,837,0002,658,0003,073,0002,028,0001,654,0001,599,0001,463,0001,543,0002,709,0002,456,0002,267,0001,484,0001,636,0001,472,0001,371,0001,480,0001,579,0001,185,0001,098,000882,0001,044,000975,000917,000992,0001,175,0001,035,0001,070,000829,000864,000873,000842,000850,000885,000968,0001,015,000855,000635,000654,000608,000894,000769,000660,000608,000467,000420,000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68,000
0
0
0
43,000
0
0
0
0
0
0
0
0
0
0
0
30,000
0
0
0
9,000
0
0
0
100,000
0
0
0
133,000
0
0
0
161,000
0
0
0
136,000
0
0
0
170,000
0
0
0
0
0000170,000000136,000000161,000000133,000000100,0000009,00000030,0000000000000043,00000068,000000000000000000
       Net Receivables 
0
0
0
2,815,000
2,985,000
3,246,000
2,914,000
3,330,000
3,415,000
3,506,000
3,501,000
3,615,000
3,915,000
3,939,000
3,931,000
4,776,000
4,178,000
4,090,000
3,952,000
4,577,000
4,084,000
4,293,000
4,480,000
5,932,000
5,224,000
5,084,000
5,129,000
6,379,000
4,903,000
4,841,000
4,958,000
6,378,000
6,298,000
5,951,000
6,105,000
7,192,000
6,875,000
6,756,000
6,591,000
8,285,000
7,445,000
7,227,000
7,222,000
9,291,000
7,802,000
7,329,000
7,304,000
9,302,000
7,776,000
7,497,000
7,553,000
9,933,000
7,983,000
8,015,000
8,146,000
10,256,000
7,869,000
7,758,000
37,681,000
4,501,000
4,501,00037,681,0007,758,0007,869,00010,256,0008,146,0008,015,0007,983,0009,933,0007,553,0007,497,0007,776,0009,302,0007,304,0007,329,0007,802,0009,291,0007,222,0007,227,0007,445,0008,285,0006,591,0006,756,0006,875,0007,192,0006,105,0005,951,0006,298,0006,378,0004,958,0004,841,0004,903,0006,379,0005,129,0005,084,0005,224,0005,932,0004,480,0004,293,0004,084,0004,577,0003,952,0004,090,0004,178,0004,776,0003,931,0003,939,0003,915,0003,615,0003,501,0003,506,0003,415,0003,330,0002,914,0003,246,0002,985,0002,815,000000
       Other Current Assets 
0
0
0
893,000
979,000
1,117,000
1,420,000
925,000
1,010,000
1,090,000
1,069,000
1,184,000
1,115,000
2,158,000
1,966,000
544,000
1,278,000
1,328,000
1,377,000
474,000
1,563,000
1,824,000
1,731,000
588,000
1,824,000
1,859,000
1,696,000
634,000
1,929,000
2,075,000
1,940,000
623,000
2,027,000
2,282,000
2,129,000
515,000
2,116,000
2,188,000
2,367,000
478,000
2,461,000
2,560,000
2,673,000
553,000
2,772,000
2,724,000
2,839,000
527,000
2,948,000
2,957,000
3,111,000
564,000
3,519,000
3,977,000
4,170,000
845,000
3,965,000
4,058,000
3,396,000
3,213,000
3,213,0003,396,0004,058,0003,965,000845,0004,170,0003,977,0003,519,000564,0003,111,0002,957,0002,948,000527,0002,839,0002,724,0002,772,000553,0002,673,0002,560,0002,461,000478,0002,367,0002,188,0002,116,000515,0002,129,0002,282,0002,027,000623,0001,940,0002,075,0001,929,000634,0001,696,0001,859,0001,824,000588,0001,731,0001,824,0001,563,000474,0001,377,0001,328,0001,278,000544,0001,966,0002,158,0001,115,0001,184,0001,069,0001,090,0001,010,000925,0001,420,0001,117,000979,000893,000000
   > Long-term Assets 
0
0
0
15,519,000
16,253,000
17,433,000
16,342,000
17,142,000
16,764,000
17,157,000
17,871,000
19,170,000
20,860,000
21,791,000
21,604,000
22,551,000
23,044,000
22,716,000
22,490,000
24,786,000
25,628,000
26,038,000
28,134,000
29,869,000
32,344,000
31,758,000
31,619,000
32,253,000
31,861,000
32,821,000
32,940,000
34,648,000
41,341,000
40,098,000
40,227,000
40,529,000
40,093,000
40,695,000
41,130,000
41,913,000
50,027,000
50,078,000
51,579,000
51,742,000
52,631,000
52,401,000
51,488,000
50,874,000
52,273,000
52,754,000
53,747,000
54,501,000
55,112,000
57,294,000
60,885,000
58,136,000
57,451,000
57,108,000
30,493,000
32,764,000
32,764,00030,493,00057,108,00057,451,00058,136,00060,885,00057,294,00055,112,00054,501,00053,747,00052,754,00052,273,00050,874,00051,488,00052,401,00052,631,00051,742,00051,579,00050,078,00050,027,00041,913,00041,130,00040,695,00040,093,00040,529,00040,227,00040,098,00041,341,00034,648,00032,940,00032,821,00031,861,00032,253,00031,619,00031,758,00032,344,00029,869,00028,134,00026,038,00025,628,00024,786,00022,490,00022,716,00023,044,00022,551,00021,604,00021,791,00020,860,00019,170,00017,871,00017,157,00016,764,00017,142,00016,342,00017,433,00016,253,00015,519,000000
       Property Plant Equipment 
0
0
0
3,559,000
3,672,000
3,881,000
3,778,000
3,954,000
3,850,000
3,880,000
3,985,000
4,210,000
4,543,000
4,681,000
4,685,000
4,918,000
4,977,000
4,966,000
4,967,000
5,082,000
6,099,000
6,340,000
6,509,000
6,776,000
7,133,000
7,104,000
7,093,000
7,428,000
7,451,000
7,645,000
7,730,000
8,138,000
9,420,000
9,239,000
9,230,000
9,555,000
9,496,000
9,714,000
9,939,000
10,366,000
16,315,000
16,414,000
16,825,000
17,266,000
17,637,000
17,663,000
17,427,000
17,603,000
17,914,000
17,940,000
18,126,000
18,583,000
18,643,000
19,181,000
19,627,000
18,841,000
18,576,000
18,535,000
10,865,000
10,782,000
10,782,00010,865,00018,535,00018,576,00018,841,00019,627,00019,181,00018,643,00018,583,00018,126,00017,940,00017,914,00017,603,00017,427,00017,663,00017,637,00017,266,00016,825,00016,414,00016,315,00010,366,0009,939,0009,714,0009,496,0009,555,0009,230,0009,239,0009,420,0008,138,0007,730,0007,645,0007,451,0007,428,0007,093,0007,104,0007,133,0006,776,0006,509,0006,340,0006,099,0005,082,0004,967,0004,966,0004,977,0004,918,0004,685,0004,681,0004,543,0004,210,0003,985,0003,880,0003,850,0003,954,0003,778,0003,881,0003,672,0003,559,000000
       Goodwill 
0
0
0
10,356,000
10,930,000
11,902,000
11,104,000
11,464,000
11,052,000
11,399,000
11,886,000
12,669,000
14,275,000
14,892,000
0
15,014,000
15,408,000
15,176,000
14,864,000
14,826,000
16,674,000
16,952,000
18,703,000
19,868,000
21,693,000
21,155,000
21,084,000
21,523,000
20,947,000
21,639,000
21,633,000
22,774,000
26,169,000
25,289,000
25,262,000
25,285,000
24,949,000
25,143,000
25,370,000
25,713,000
27,164,000
27,094,000
27,900,000
27,737,000
28,236,000
27,964,000
27,342,000
26,599,000
27,523,000
27,675,000
28,338,000
28,943,000
29,373,000
30,838,000
33,265,000
31,444,000
31,045,000
30,993,000
15,723,000
15,089,000
15,089,00015,723,00030,993,00031,045,00031,444,00033,265,00030,838,00029,373,00028,943,00028,338,00027,675,00027,523,00026,599,00027,342,00027,964,00028,236,00027,737,00027,900,00027,094,00027,164,00025,713,00025,370,00025,143,00024,949,00025,285,00025,262,00025,289,00026,169,00022,774,00021,633,00021,639,00020,947,00021,523,00021,084,00021,155,00021,693,00019,868,00018,703,00016,952,00016,674,00014,826,00014,864,00015,176,00015,408,00015,014,000014,892,00014,275,00012,669,00011,886,00011,399,00011,052,00011,464,00011,104,00011,902,00010,930,00010,356,000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
803,000
5,000
3,000
3,000
734,000
0
0
0
1,134,000
0
0
0
1,304,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,304,0000001,134,000000734,0003,0003,0005,000803,0000000000000000000000000000000000
       Intangible Assets 
0
0
0
1,053,000
1,112,000
1,023,000
927,000
984,000
935,000
908,000
1,001,000
981,000
988,000
1,042,000
0
1,284,000
1,280,000
1,234,000
1,182,000
1,241,000
1,229,000
1,226,000
1,338,000
1,446,000
1,594,000
1,524,000
1,486,000
1,510,000
1,454,000
1,490,000
1,467,000
1,571,000
3,010,000
2,880,000
3,182,000
3,172,000
3,143,000
3,124,000
3,109,000
3,130,000
3,631,000
3,880,000
3,968,000
3,869,000
3,891,000
3,832,000
3,769,000
3,736,000
3,752,000
3,754,000
3,771,000
3,831,000
3,836,000
4,097,000
4,584,000
4,399,000
4,249,000
4,172,000
2,665,000
2,531,000
2,531,0002,665,0004,172,0004,249,0004,399,0004,584,0004,097,0003,836,0003,831,0003,771,0003,754,0003,752,0003,736,0003,769,0003,832,0003,891,0003,869,0003,968,0003,880,0003,631,0003,130,0003,109,0003,124,0003,143,0003,172,0003,182,0002,880,0003,010,0001,571,0001,467,0001,490,0001,454,0001,510,0001,486,0001,524,0001,594,0001,446,0001,338,0001,226,0001,229,0001,241,0001,182,0001,234,0001,280,0001,284,00001,042,000988,000981,0001,001,000908,000935,000984,000927,0001,023,0001,112,0001,053,000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,570,000
1,662,000
1,739,000
1,606,000
2,937,000
2,865,000
3,077,000
2,382,000
3,078,000
3,287,000
3,283,000
2,210,000
2,677,000
2,690,000
2,886,000
2,231,000
2,867,000
2,942,000
2,950,000
2,220,000
3,084,000
3,385,000
3,512,000
2,442,000
3,260,000
3,178,000
3,409,000
3,452,000
3,581,000
3,408,000
1,240,000
0
01,240,0003,408,0003,581,0003,452,0003,409,0003,178,0003,260,0002,442,0003,512,0003,385,0003,084,0002,220,0002,950,0002,942,0002,867,0002,231,0002,886,0002,690,0002,677,0002,210,0003,283,0003,287,0003,078,0002,382,0003,077,0002,865,0002,937,0001,606,0001,739,0001,662,0001,570,0000000000000000000000000000000
> Total Liabilities 
0
0
0
13,230,000
13,866,000
15,272,000
14,213,000
14,733,000
14,784,000
15,205,000
14,658,000
15,744,000
17,713,000
18,534,000
17,693,000
17,508,000
17,581,000
17,602,000
17,299,000
19,026,000
20,205,000
21,302,000
22,247,000
23,733,000
24,990,000
24,591,000
24,140,000
24,220,000
23,478,000
24,258,000
23,891,000
24,843,000
32,497,000
31,877,000
31,930,000
31,413,000
31,482,000
31,713,000
31,725,000
31,695,000
39,155,000
39,547,000
40,063,000
40,426,000
42,016,000
42,302,000
42,120,000
40,623,000
41,452,000
42,524,000
42,895,000
42,674,000
42,530,000
44,079,000
46,172,000
44,197,000
44,380,000
44,983,000
45,046,000
25,633,000
25,633,00045,046,00044,983,00044,380,00044,197,00046,172,00044,079,00042,530,00042,674,00042,895,00042,524,00041,452,00040,623,00042,120,00042,302,00042,016,00040,426,00040,063,00039,547,00039,155,00031,695,00031,725,00031,713,00031,482,00031,413,00031,930,00031,877,00032,497,00024,843,00023,891,00024,258,00023,478,00024,220,00024,140,00024,591,00024,990,00023,733,00022,247,00021,302,00020,205,00019,026,00017,299,00017,602,00017,581,00017,508,00017,693,00018,534,00017,713,00015,744,00014,658,00015,205,00014,784,00014,733,00014,213,00015,272,00013,866,00013,230,000000
   > Total Current Liabilities 
0
0
0
3,528,000
4,830,000
6,321,000
5,435,000
5,711,000
5,428,000
5,741,000
5,152,000
5,988,000
7,845,000
8,013,000
5,882,000
5,198,000
5,906,000
5,802,000
5,444,000
6,023,000
5,697,000
6,034,000
7,286,000
7,104,000
7,650,000
7,409,000
7,102,000
7,409,000
7,399,000
8,057,000
8,450,000
8,544,000
10,184,000
10,369,000
10,647,000
10,665,000
11,248,000
12,123,000
13,296,000
13,275,000
13,672,000
13,745,000
13,780,000
13,884,000
15,990,000
15,443,000
13,855,000
13,216,000
15,947,000
15,204,000
15,352,000
15,062,000
14,138,000
14,300,000
14,862,000
13,658,000
15,919,000
16,057,000
29,189,000
9,330,000
9,330,00029,189,00016,057,00015,919,00013,658,00014,862,00014,300,00014,138,00015,062,00015,352,00015,204,00015,947,00013,216,00013,855,00015,443,00015,990,00013,884,00013,780,00013,745,00013,672,00013,275,00013,296,00012,123,00011,248,00010,665,00010,647,00010,369,00010,184,0008,544,0008,450,0008,057,0007,399,0007,409,0007,102,0007,409,0007,650,0007,104,0007,286,0006,034,0005,697,0006,023,0005,444,0005,802,0005,906,0005,198,0005,882,0008,013,0007,845,0005,988,0005,152,0005,741,0005,428,0005,711,0005,435,0006,321,0004,830,0003,528,000000
       Short-term Debt 
0
0
0
550,000
1,504,000
2,187,000
855,000
2,050,000
1,214,000
1,807,000
1,494,000
2,026,000
3,172,000
3,721,000
1,680,000
794,000
1,412,000
1,453,000
1,240,000
1,852,000
1,354,000
1,381,000
2,203,000
1,758,000
1,742,000
1,564,000
1,237,000
1,162,000
1,466,000
1,841,000
2,122,000
2,059,000
2,443,000
2,791,000
3,003,000
2,899,000
3,434,000
3,993,000
4,954,000
5,094,000
5,420,000
5,627,000
5,307,000
5,508,000
7,397,000
5,578,000
3,729,000
3,670,000
6,116,000
5,274,000
5,049,000
4,772,000
3,934,000
3,734,000
3,366,000
3,036,000
5,061,000
5,020,000
2,346,000
2,581,000
2,581,0002,346,0005,020,0005,061,0003,036,0003,366,0003,734,0003,934,0004,772,0005,049,0005,274,0006,116,0003,670,0003,729,0005,578,0007,397,0005,508,0005,307,0005,627,0005,420,0005,094,0004,954,0003,993,0003,434,0002,899,0003,003,0002,791,0002,443,0002,059,0002,122,0001,841,0001,466,0001,162,0001,237,0001,564,0001,742,0001,758,0002,203,0001,381,0001,354,0001,852,0001,240,0001,453,0001,412,000794,0001,680,0003,721,0003,172,0002,026,0001,494,0001,807,0001,214,0002,050,000855,0002,187,0001,504,000550,000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,670,000
2,045,000
2,385,000
2,043,000
20,211,000
19,911,000
1,122,000
1,326,000
1,638,000
1,993,000
2,699,000
2,568,000
4,641,000
4,879,000
4,532,000
4,715,000
6,589,000
4,779,000
2,854,000
2,904,000
5,320,000
4,487,000
4,243,000
3,940,000
3,084,000
2,849,000
2,455,000
2,185,000
4,218,000
4,181,000
2,130,000
2,375,000
2,375,0002,130,0004,181,0004,218,0002,185,0002,455,0002,849,0003,084,0003,940,0004,243,0004,487,0005,320,0002,904,0002,854,0004,779,0006,589,0004,715,0004,532,0004,879,0004,641,0002,568,0002,699,0001,993,0001,638,0001,326,0001,122,00019,911,00020,211,0002,043,0002,385,0002,045,0001,670,0000000000000000000000000000000
       Accounts payable 
0
0
0
601,000
583,000
623,000
593,000
693,000
624,000
696,000
619,000
828,000
819,000
823,000
756,000
961,000
835,000
839,000
778,000
885,000
812,000
856,000
903,000
1,052,000
1,136,000
1,036,000
1,029,000
1,291,000
1,033,000
1,084,000
1,040,000
1,315,000
1,409,000
1,437,000
1,400,000
1,688,000
1,479,000
1,527,000
1,574,000
1,823,000
1,760,000
1,719,000
1,665,000
1,905,000
1,819,000
1,664,000
1,690,000
1,816,000
1,635,000
1,669,000
1,649,000
2,039,000
1,897,000
1,929,000
1,926,000
2,070,000
1,998,000
1,925,000
1,217,000
1,985,000
1,985,0001,217,0001,925,0001,998,0002,070,0001,926,0001,929,0001,897,0002,039,0001,649,0001,669,0001,635,0001,816,0001,690,0001,664,0001,819,0001,905,0001,665,0001,719,0001,760,0001,823,0001,574,0001,527,0001,479,0001,688,0001,400,0001,437,0001,409,0001,315,0001,040,0001,084,0001,033,0001,291,0001,029,0001,036,0001,136,0001,052,000903,000856,000812,000885,000778,000839,000835,000961,000756,000823,000819,000828,000619,000696,000624,000693,000593,000623,000583,000601,000000
       Other Current Liabilities 
0
0
0
383,000
2,600,000
483,000
1,066,000
2,968,000
458,000
3,238,000
3,039,000
3,134,000
500,000
3,469,000
2,000
290,000
3,350,000
3,272,000
3,165,000
323,000
3,265,000
3,554,000
3,976,000
388,000
4,575,000
4,647,000
4,684,000
4,761,000
4,634,000
4,922,000
5,026,000
439,000
5,936,000
5,833,000
5,940,000
5,896,000
6,050,000
6,272,000
6,525,000
1,758,000
6,250,000
6,203,000
6,529,000
1,943,000
6,482,000
7,899,000
175,000
2,170,000
7,887,000
7,997,000
8,330,000
2,424,000
8,307,000
8,637,000
9,570,000
7,543,000
8,860,000
8,622,000
5,309,000
1,903,000
1,903,0005,309,0008,622,0008,860,0007,543,0009,570,0008,637,0008,307,0002,424,0008,330,0007,997,0007,887,0002,170,000175,0007,899,0006,482,0001,943,0006,529,0006,203,0006,250,0001,758,0006,525,0006,272,0006,050,0005,896,0005,940,0005,833,0005,936,000439,0005,026,0004,922,0004,634,0004,761,0004,684,0004,647,0004,575,000388,0003,976,0003,554,0003,265,000323,0003,165,0003,272,0003,350,000290,0002,0003,469,000500,0003,134,0003,039,0003,238,000458,0002,968,0001,066,000483,0002,600,000383,000000
   > Long-term Liabilities 
0
0
0
9,702,000
9,036,000
8,951,000
8,778,000
9,022,000
9,356,000
9,464,000
9,506,000
9,756,000
9,868,000
10,521,000
11,811,000
12,310,000
11,675,000
11,800,000
11,855,000
13,003,000
14,508,000
15,268,000
14,961,000
16,629,000
17,340,000
17,182,000
17,038,000
16,811,000
16,079,000
16,201,000
15,441,000
16,299,000
22,313,000
21,508,000
21,283,000
20,748,000
20,234,000
19,590,000
18,429,000
18,420,000
25,483,000
25,802,000
26,283,000
26,542,000
26,026,000
26,859,000
28,265,000
27,407,000
25,505,000
27,320,000
27,543,000
27,612,000
28,392,000
29,779,000
31,310,000
30,539,000
28,461,000
28,926,000
15,857,000
16,303,000
16,303,00015,857,00028,926,00028,461,00030,539,00031,310,00029,779,00028,392,00027,612,00027,543,00027,320,00025,505,00027,407,00028,265,00026,859,00026,026,00026,542,00026,283,00025,802,00025,483,00018,420,00018,429,00019,590,00020,234,00020,748,00021,283,00021,508,00022,313,00016,299,00015,441,00016,201,00016,079,00016,811,00017,038,00017,182,00017,340,00016,629,00014,961,00015,268,00014,508,00013,003,00011,855,00011,800,00011,675,00012,310,00011,811,00010,521,0009,868,0009,756,0009,506,0009,464,0009,356,0009,022,0008,778,0008,951,0009,036,0009,702,000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,958,000
21,252,000
21,706,000
21,750,000
21,160,000
21,909,000
23,267,000
22,243,000
20,392,000
22,015,000
22,142,000
22,383,000
23,277,000
24,634,000
25,241,000
24,727,000
22,704,000
23,163,000
12,770,000
0
012,770,00023,163,00022,704,00024,727,00025,241,00024,634,00023,277,00022,383,00022,142,00022,015,00020,392,00022,243,00023,267,00021,909,00021,160,00021,750,00021,706,00021,252,00020,958,0000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,993,000
2,559,000
2,544,000
3,154,000
4,545,000
4,388,000
4,789,000
4,604,000
4,468,000
4,594,000
4,422,000
4,380,000
4,525,000
4,550,000
4,577,000
4,792,000
4,866,000
4,950,000
4,998,000
5,164,000
5,113,000
5,305,000
5,401,000
5,229,000
5,115,000
5,145,000
6,069,000
0
0
0
0
0
000006,069,0005,145,0005,115,0005,229,0005,401,0005,305,0005,113,0005,164,0004,998,0004,950,0004,866,0004,792,0004,577,0004,550,0004,525,0004,380,0004,422,0004,594,0004,468,0004,604,0004,789,0004,388,0004,545,0003,154,0002,544,0002,559,0002,993,0000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
950,000
864,000
865,000
986,000
200,000
178,000
527,000
599,000
573,000
573,000
571,000
640,000
638,000
677,000
698,000
665,000
0
0
0
681,000
0
0
0
708,000
0
0
0
0
0
0
0
0
00000000708,000000681,000000665,000698,000677,000638,000640,000571,000573,000573,000599,000527,000178,000200,000986,000865,000864,000950,0000000000000000000000000000000
> Total Stockholder Equity
0
0
0
4,270,000
4,526,000
4,741,000
4,725,000
4,965,000
4,964,000
4,921,000
5,699,000
5,971,000
6,090,000
7,315,000
7,502,000
7,633,000
7,940,000
7,811,000
7,846,000
8,195,000
8,437,000
8,511,000
9,150,000
9,335,000
10,287,000
10,164,000
10,384,000
10,935,000
11,039,000
11,311,000
11,745,000
12,503,000
13,525,000
13,076,000
13,221,000
13,661,000
13,884,000
14,381,000
14,816,000
15,411,000
16,002,000
15,880,000
16,670,000
16,778,000
17,179,000
17,473,000
16,901,000
16,949,000
17,807,000
17,699,000
18,301,000
18,998,000
19,870,000
20,664,000
21,382,000
20,415,000
20,532,000
20,086,000
20,034,000
18,999,000
18,999,00020,034,00020,086,00020,532,00020,415,00021,382,00020,664,00019,870,00018,998,00018,301,00017,699,00017,807,00016,949,00016,901,00017,473,00017,179,00016,778,00016,670,00015,880,00016,002,00015,411,00014,816,00014,381,00013,884,00013,661,00013,221,00013,076,00013,525,00012,503,00011,745,00011,311,00011,039,00010,935,00010,384,00010,164,00010,287,0009,335,0009,150,0008,511,0008,437,0008,195,0007,846,0007,811,0007,940,0007,633,0007,502,0007,315,0006,090,0005,971,0005,699,0004,921,0004,964,0004,965,0004,725,0004,741,0004,526,0004,270,000000
   Common Stock
0
0
0
161,000
161,000
162,000
162,000
162,000
162,000
163,000
163,000
163,000
163,000
177,000
178,000
178,000
178,000
178,000
179,000
180,000
180,000
180,000
181,000
542,000
543,000
544,000
545,000
546,000
546,000
546,000
547,000
547,000
553,000
554,000
555,000
555,000
555,000
556,000
556,000
556,000
556,000
557,000
557,000
557,000
557,000
557,000
557,000
557,000
557,000
558,000
558,000
558,000
558,000
563,000
563,000
563,000
563,000
563,000
563,000
563,000
563,000563,000563,000563,000563,000563,000563,000558,000558,000558,000558,000557,000557,000557,000557,000557,000557,000557,000557,000556,000556,000556,000556,000555,000555,000555,000554,000553,000547,000547,000546,000546,000546,000545,000544,000543,000542,000181,000180,000180,000180,000179,000178,000178,000178,000178,000177,000163,000163,000163,000163,000162,000162,000162,000162,000161,000161,000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-4,385,000
0
0
0
-4,727,000
0
0
0
-5,551,000
0
0
0
-6,420,000
0
0
0
-7,251,000
0
0
0
-7,617,000
0
0
0
-8,515,000
0
0
0
-9,356,000
0
0
0
-11,553,000
0
0
0
0
0
0
0
407,000
146,000
110,000
430,000
18,000
18,000430,000110,000146,000407,0000000000-11,553,000000-9,356,000000-8,515,000000-7,617,000000-7,251,000000-6,420,000000-5,551,000000-4,727,000000-4,385,000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
4,109,000
4,365,000
4,579,000
4,563,000
4,768,000
4,902,000
4,900,000
5,612,000
5,808,000
5,934,000
7,138,000
7,262,000
7,583,000
7,805,000
7,767,000
7,889,000
8,366,000
8,630,000
8,698,000
9,008,000
8,912,000
9,259,000
9,363,000
9,735,000
10,109,000
10,467,000
10,552,000
10,988,000
11,432,000
12,402,000
12,576,000
12,985,000
13,504,000
13,952,000
14,214,000
14,659,000
15,185,000
15,604,000
15,550,000
15,960,000
16,411,000
16,770,000
17,172,000
17,107,000
17,527,000
17,961,000
17,141,000
17,743,000
18,440,000
19,312,000
20,101,000
20,819,000
4,323,000
4,321,000
4,323,000
4,325,000
4,326,000
4,326,0004,325,0004,323,0004,321,0004,323,00020,819,00020,101,00019,312,00018,440,00017,743,00017,141,00017,961,00017,527,00017,107,00017,172,00016,770,00016,411,00015,960,00015,550,00015,604,00015,185,00014,659,00014,214,00013,952,00013,504,00012,985,00012,576,00012,402,00011,432,00010,988,00010,552,00010,467,00010,109,0009,735,0009,363,0009,259,0008,912,0009,008,0008,698,0008,630,0008,366,0007,889,0007,767,0007,805,0007,583,0007,262,0007,138,0005,934,0005,808,0005,612,0004,900,0004,902,0004,768,0004,563,0004,579,0004,365,0004,109,000000



Balance Sheet

Currency in EUR. All numbers in thousands.




Cash Flow

Currency in EUR. All numbers in thousands.




Income Statement

Currency in EUR. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue22,299,000
Cost of Revenue-17,241,000
Gross Profit5,058,0005,058,000
 
Operating Income (+$)
Gross Profit5,058,000
Operating Expense-3,915,000
Operating Income1,143,0001,143,000
 
Operating Expense (+$)
Research Development661,000
Selling General Administrative2,405,000
Selling And Marketing Expenses750,000
Operating Expense3,915,0003,816,000
 
Net Interest Income (+$)
Interest Income118,000
Interest Expense-534,000
Other Finance Cost-222,000
Net Interest Income-638,000
 
Pretax Income (+$)
Operating Income1,143,000
Net Interest Income-638,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)715,0001,571,000
EBIT - interestExpense = 715,000
-117,000
-60,000
Interest Expense534,000
Earnings Before Interest and Taxes (EBIT)1,249,0001,249,000
Earnings Before Interest and Taxes (EBITDA)2,727,000
 
After tax Income (+$)
Income Before Tax715,000
Tax Provision-707,000
Net Income From Continuing Ops1,559,0008,000
Net Income-594,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses21,156,000
Total Other Income/Expenses Net-428,000638,000
 

Technical Analysis of Fresenius
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fresenius. The general trend of Fresenius is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fresenius's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Fresenius SE & Co. KGaA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 27.50 < 29.20 < 29.38.

The bearish price targets are: 27.17 > 25.85 > 24.41.

Tweet this
Fresenius SE & Co. KGaA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Fresenius SE & Co. KGaA. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Fresenius SE & Co. KGaA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Fresenius SE & Co. KGaA. The current macd is 0.5419025.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Fresenius price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Fresenius. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Fresenius price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Fresenius SE & Co. KGaA Daily Moving Average Convergence/Divergence (MACD) ChartFresenius SE & Co. KGaA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Fresenius SE & Co. KGaA. The current adx is 34.73.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Fresenius shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Fresenius SE & Co. KGaA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Fresenius SE & Co. KGaA. The current sar is 26.51.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Fresenius SE & Co. KGaA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Fresenius SE & Co. KGaA. The current rsi is 65.93. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Fresenius SE & Co. KGaA Daily Relative Strength Index (RSI) ChartFresenius SE & Co. KGaA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Fresenius SE & Co. KGaA. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Fresenius price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Fresenius SE & Co. KGaA Daily Stochastic Oscillator ChartFresenius SE & Co. KGaA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Fresenius SE & Co. KGaA. The current cci is 85.72.

Fresenius SE & Co. KGaA Daily Commodity Channel Index (CCI) ChartFresenius SE & Co. KGaA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Fresenius SE & Co. KGaA. The current cmo is 38.00.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Fresenius SE & Co. KGaA Daily Chande Momentum Oscillator (CMO) ChartFresenius SE & Co. KGaA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Fresenius SE & Co. KGaA. The current willr is -25.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Fresenius is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Fresenius SE & Co. KGaA Daily Williams %R ChartFresenius SE & Co. KGaA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Fresenius SE & Co. KGaA.

Fresenius SE & Co. KGaA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Fresenius SE & Co. KGaA. The current atr is 0.54323273.

Fresenius SE & Co. KGaA Daily Average True Range (ATR) ChartFresenius SE & Co. KGaA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Fresenius SE & Co. KGaA. The current obv is 1,612,498.

Fresenius SE & Co. KGaA Daily On-Balance Volume (OBV) ChartFresenius SE & Co. KGaA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Fresenius SE & Co. KGaA. The current mfi is 58.08.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Fresenius SE & Co. KGaA Daily Money Flow Index (MFI) ChartFresenius SE & Co. KGaA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Fresenius SE & Co. KGaA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Fresenius SE & Co. KGaA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Fresenius SE & Co. KGaA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.925
Ma 20Greater thanMa 5026.025
Ma 50Greater thanMa 10025.713
Ma 100Greater thanMa 20026.545
OpenGreater thanClose27.120
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Fresenius with someone you think should read this too:
  • Are you bullish or bearish on Fresenius? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fresenius? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Fresenius SE & Co. KGaA

I send you an email if I find something interesting about Fresenius SE & Co. KGaA.


Comments

How you think about this?

Leave a comment

Stay informed about Fresenius SE & Co. KGaA.

Receive notifications about Fresenius SE & Co. KGaA in your mailbox!